Anxiety Disorders Case Study

/in /by

Anxiety Disorders Case Study

. List specific treatment goals for Ivy.

In the case of Ivy, the young woman has been experiencing anxiety related to her childhood wearisomeness. Her anxiety has reached a point where it has prevented her from engaging in activities she would normally take part in. The most important goal for Ivy is to find an effective way to reduce her anxiety symptoms and restore her confidence (Levy et al., 2021). Cognitive Behavioral Therapy, or CBT, is an effective treatment for anxiety and could help Ivy address negative thought patterns, learn to recognize her triggers, and develop coping skills.

  1. What drug therapy would you prescribe? Why?

Since Ivy is experiencing a significant level of anxiety, drug therapy may also be appropriate to help reduce her symptoms. Selective Serotonin Reuptake Inhibitors (SSRIs) are the most commonly prescribed antidepressants for anxiety disorders; SSRIs help balance serotonin, a neurotransmitter known to affect mood and behavior (Gosmann et al., 2021). The usual starting dosage for SSRIs is low and then titrated up as needed. Ivy should be prescribed an SSRI at an initial dosage of 10-20mg per day, divided into two doses for convenience. This dosage should be re-evaluated every two weeks, and adjust the dosage accordingly. SSRIs can help to reduce symptoms of anxiety and depression, stabilize mood, and improve concentration and focus. However, it is important to note that drug therapy is only effective when combined with other treatments, such as CBT or psychotherapy, which can help to identify the triggers associated with Ivy’s anxiety and ultimately help her to develop better strategies for managing her anxiety.

  1. What are the parameters for monitoring the success of the therapy?

In order to determine the success of an individual’s treatment, it is imperative to observe how the symptoms are progressing throughout the process and determine whether or not the therapy has a positive impact. When it comes to monitoring the success of CBT, it is important to observe patient behavior to assess the therapy’s effects. This can include observing changes in attitude and behavior and the patient’s anxiety levels. Additionally, it is important to track the patient’s progress in managing their anxiety and using healthy coping strategies (Silberman et al., 2021). Ultimately, CBT aims to help the patient gain greater self-regulation and efficacy, so it is important to assess whether this has occurred.

  1. Describe specific patient monitoring based on the prescribed therapy.

When it comes to monitoring the success of drug therapy it is critical to monitor the patient’s symptoms and behaviors to determine if the drug is having a positive effect. Additionally monitoring the patient’s side effects to detect any adverse reactions to the medication and adjust the dosage accordingly is important. Ultimately, drug therapy aims to improve the patient’s symptoms and quality of life, so it is important to assess whether or not this has been achieved (Woo & Robinson, 2019). It is also worth mentioning that monitoring the success of therapy for anxiety disorders is an important part of the treatment process. Observing, the patient’s behavior and symptoms make it possible to determine whether the therapy is having a positive effect or if further adjustments or treatments are needed. Anxiety disorders can be effectively treated with rate monitoring.

  1. One, or two adverse reactions for the selected agent that would cause you to change therapy.

One potential adverse reaction to be aware of in using SSRIs is the increased risk of suicidal thoughts and behaviors. When starting a patient on an SSRI, it is important to closely monitor the patient for any signs or symptoms of suicidal ideation. If a patient is at an increased risk for suicide or exhibits signs or symptoms, it is important to adjust or discontinue the treatment immediately (Zemestani et al., 2021). Another potential adverse reaction to be aware of is sexual dysfunction. Suppose a patient has reported any issues with sexual dysfunction. In that case, it is important to select a different SSRI, as SSRIs have been known to have varying levels of impact on sexual functioning.

  1. What would be the choice for second-line therapy?

If SSRIs are not an appropriate treatment for the patient, a second-line therapy option can be to consider other forms of talking therapy, such as Cognitive Behavioral Therapy (CBT). CBT is a form of psychotherapy focused on helping individuals identify and challenge negative beliefs and behaviors perpetuating their anxiety (Woo & Robinson, 2019). CBT is a useful tool for helping individuals confront their fears and manage their anxiety effectively (Levy et al., 2021). In the case of Ivy, a 23-year-old experiencing anxiety, a suitable prescription of CBT would involve cognitive restructuring. Cognitive restructuring is a technique used to identify and challenge irrational or harmful thoughts while promoting more healthy, realistic thinking. This type of therapy would focus on identifying automatic negative and irrational thinking patterns that lead to anxiety-producing behavior and replace them with more helpful and rational beliefs. Cognitive restructuring would also involve applying problem-solving approaches to address difficult situations.

In addition to cognitive restructuring, relaxation techniques can also be used to help with anxiety. Relaxation techniques can help reduce the physical and cognitive symptoms of anxiety by focusing on deep breathing, muscle relaxation, and distraction techniques. Thus, an appropriate course of CBT for Ivy would involve cognitive restructuring and relaxation techniques to help her manage her anxiety. Overall, it is important to consider a patient’s circumstances when selecting appropriate therapy and consider any potential adverse reactions to the chosen agent. While SSRIs may be one option for treating anxiety disorders, it is important to consider other therapeutic approaches and adjust or discontinue the treatment if necessary.

  1. What dietary and lifestyle changes should be recommended for this patient?

When considering dietary and lifestyle changes for a patient suffering from anxiety, it is important to note that diet and lifestyle can greatly influence overall mental well-being. To this end, the patient should be encouraged to maintain a healthy balance of macronutrients, incorporate fresh fruits and vegetables into their diet, and exercise regularly (Silberman et al., 2021). It is also important to ensure that the patient can practice mindfulness, learning to be aware of the present moment so that they can observe their thoughts and feelings without judgment.

  1. Describe one or two drug–or drug–food interactions for the selected agent.

Regarding drug-drug or drug-food interactions, selecting Selective Serotonin Reuptake Inhibitor (SSRI) medications is important. These can interact with certain foods, such as grapefruit, and certain medications, such as Monoamine oxidase (MAO) inhibitors (Zemestani et al., 2021). Additionally, patients should be aware of the potential for SSRIs to interact with other medications that can increase serotonin levels, such as St John’s wort, as these can lead to serotonin overload and possible side effects. Similarly, alcohol should be avoided, as this can further exacerbate anxiety symptoms.

References

Gosmann, N. P., De Abreu Costa, M., De Barros Jaeger, M., Motta, L. S., Frozi, J., Spanemberg, L., Manfro, G. G., Cuijpers, P., Pine, D. S., & Salum, G. A. (2021). Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis. PLOS Medicine, 18(6), e1003664. https://doi.org/10.1371/journal.pmed.1003664

Levy, H. C., O’Bryan, E. M., & Tolin, D. F. (2021). A meta-analysis of relapse rates in cognitive-behavioral therapy for anxiety disorders. Journal of Anxiety Disorders, p. 81, 102407. https://doi.org/10.1016/j.janxdis.2021.102407

Silberman, E., Balon, R., Starcevic, V., Shader, R., Cosci, F., Fava, G. A., … & Sonino, N. (2021). Benzodiazepines: it’s time to return to the evidence. The British Journal of Psychiatry, 218(3), 125-127. https://doi.org/10.1192/bjp.2020.164

Woo, T. M., & Robinson, M. V. (2019). Pharmacotherapeutics for Advanced Practice Nurse Prescribers.

Zemestani, M., Beheshti, N., Rezaei, F., Van Der Heiden, C., & Kendall, P. C. (2021). Cognitive Behavior Therapy Targeting Intolerance of Uncertainty Versus Selective Serotonin Reuptake Inhibitor for Generalized Anxiety Disorder: A Randomized Clinical Trial. Behavior Change, 38(4), 250–262. https://doi.org/10.1017/bec.2021.16

CLICK HERE TO ORDER A PLAGIARISM-FREE PAPER

Anxiety Disorders Case Study